It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
FTRE’s FA Score shows that 1 FA rating(s) are green whileMORN’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
FTRE’s TA Score shows that 5 TA indicator(s) are bullish while MORN’s TA Score has 5 bullish TA indicator(s).
FTRE (@Biotechnology) experienced а +3.75% price change this week, while MORN (@Investment Banks/Brokers) price change was +1.23% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.36%. For the same industry, the average monthly price growth was +8.08%, and the average quarterly price growth was -5.89%.
The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was +1.49%. For the same industry, the average monthly price growth was +2.24%, and the average quarterly price growth was +109.84%.
FTRE is expected to report earnings on May 12, 2025.
MORN is expected to report earnings on Jul 23, 2025.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Investment Banks/Brokers (+1.49% weekly)These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.
FTRE | MORN | FTRE / MORN | |
Capitalization | 550M | 13.2B | 4% |
EBITDA | -64.3M | 427M | -15% |
Gain YTD | -67.399 | -15.669 | 430% |
P/E Ratio | N/A | 93.13 | - |
Revenue | 2.7B | 2.04B | 132% |
Total Cash | 118M | 389M | 30% |
Total Debt | 1.2B | 1.16B | 103% |
MORN | ||
---|---|---|
OUTLOOK RATING 1..100 | 11 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 84 Overvalued | |
PROFIT vs RISK RATING 1..100 | 38 | |
SMR RATING 1..100 | 39 | |
PRICE GROWTH RATING 1..100 | 61 | |
P/E GROWTH RATING 1..100 | 93 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FTRE | MORN | |
---|---|---|
RSI ODDS (%) | 2 days ago77% | 2 days ago64% |
Stochastic ODDS (%) | 2 days ago81% | 2 days ago63% |
Momentum ODDS (%) | 2 days ago67% | 2 days ago70% |
MACD ODDS (%) | 2 days ago59% | 2 days ago62% |
TrendWeek ODDS (%) | 2 days ago68% | 2 days ago63% |
TrendMonth ODDS (%) | 2 days ago80% | 2 days ago48% |
Advances ODDS (%) | 4 days ago68% | 3 days ago65% |
Declines ODDS (%) | 2 days ago83% | 25 days ago53% |
BollingerBands ODDS (%) | 2 days ago81% | 2 days ago67% |
Aroon ODDS (%) | 2 days ago79% | N/A |
A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with BHVN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then BHVN could also see price increases.
Ticker / NAME | Correlation To FTRE | 1D Price Change % | ||
---|---|---|---|---|
FTRE | 100% | -2.41% | ||
BHVN - FTRE | 44% Loosely correlated | +1.49% | ||
TECH - FTRE | 41% Loosely correlated | -1.43% | ||
JAZZ - FTRE | 41% Loosely correlated | +0.19% | ||
DNLI - FTRE | 40% Loosely correlated | -3.54% | ||
OCUL - FTRE | 38% Loosely correlated | +2.77% | ||
More |
A.I.dvisor indicates that over the last year, MORN has been closely correlated with MCO. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if MORN jumps, then MCO could also see price increases.
Ticker / NAME | Correlation To MORN | 1D Price Change % | ||
---|---|---|---|---|
MORN | 100% | -0.55% | ||
MCO - MORN | 75% Closely correlated | -0.28% | ||
NDAQ - MORN | 73% Closely correlated | -0.09% | ||
SPGI - MORN | 71% Closely correlated | -0.22% | ||
MC - MORN | 63% Loosely correlated | -0.32% | ||
GS - MORN | 62% Loosely correlated | +1.15% | ||
More |